Similar articles

• Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.

  Wolfs TF, Nara PL, Goudsmit J. Wolfs TF, et al. Chem Immunol. 1993;56:1-33. Chem Immunol. 1993. PMID: 8383980 Review. No abstract available.
• Human immunodeficiency virus variants that escape cytotoxic T-cell recognition.

  Rowland-Jones SL, Phillips RE, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR, et al. Rowland-Jones SL, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1353-4. doi: 10.1089/aid.1992.8.1353. AIDS Res Hum Retroviruses. 1992. PMID: 1466955 No abstract available.
• How does the HIV escape cytotoxic T cell immunity?

  Phillips RE, McMichael AJ. Phillips RE, et al. Chem Immunol. 1993;56:150-64. Chem Immunol. 1993. PMID: 7680867 Review. No abstract available.
• [Role of the HIV-1 gp120 V1/V2 domains in the induction of neutralizing antibodies].

  Granados-González V, Piedrahita LD, Martínez M, Genin C, Riffard S, Urcuqui-Inchima S. Granados-González V, et al. Enferm Infecc Microbiol Clin. 2009 Nov;27(9):523-30. doi: 10.1016/j.eimc.2008.02.010. Epub 2009 May 1. Enferm Infecc Microbiol Clin. 2009. PMID: 19409660 Review. Spanish.
• In vitro inhibition of a variety of human immunodeficiency virus isolates by a broadly reactive, V3-directed heteroconjugate antibody.

  Higgins PJ, Paradis T, Potts BJ, White-Scharf ME, Rusche JR, Scott CF. Higgins PJ, et al. J Infect Dis. 1992 Jul;166(1):198-202. doi: 10.1093/infdis/166.1.198. J Infect Dis. 1992. PMID: 1607697